Mr. Iwanicki discusses the impact the Myriad Genetics case could have on the biotechnology industry in a Bloomberg article published on March 31, 2011.
Please click here to view the article.
Posted: March 31, 2011
|AWSELB||This cookie is associated with Amazon Web Services and is used for managing sticky sessions across production servers.|
|JSESSIONID||Used by sites written in JSP. General-purpose platform session cookies that are used to maintain users' state across page requests.|
|_ga||This cookie is installed by Google Analytics. The cookie is used to calculate visitors, session, campaign data and keep track of site usage for the site's analytics report. The cookies store information anonymously and assigns a randomly generated number to identify unique visitors.|
|_gid||This cookie is installed by Google Analytics. The cookie is used to store information on how visitors use a website and helps in creating an analytics report of how the website is doing. The data collected including the number visitors, the source where they have come from, and the pages visited in an anonymous form.|
|_gat||This cookies is installed by Google Universal Analytics to throttle the request rate to limit the collection of data on high traffic sites.|